Paper17560554
Inhibition of the HERG potassium channel by the tricyclic antidepressant doxepin.
Duncan RS and 8 others. Biochem Pharmacol, 2007. Cited by 43 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Inhibition of the HERG potassium channel by the tricyclic antidepressant doxepin. Papers, record 17560554. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/17560554
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antidepressive Agents, Tricyclic | Major topic |
| Doxepin | Major topic |
| Ether-A-Go-Go Potassium Channels | Major topic |
| Animals | |
| Cells, Cultured | |
| ERG1 Potassium Channel | |
| Heart Ventricles | |
| Patch-Clamp Techniques | |
| Rabbits |
Source PubMed
References63
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 9,486,667 | Molecular determinants of dofetilide block of HERG K+ channels. | Circ Res | 1998 | https://conductscience.org/library/papers/9486667 | PubMed |
| 2 | 9,449,325 | Properties of HERG channels stably expressed in HEK 293 cells studied at physiological temperature. | Biophys J | 1998 | https://conductscience.org/library/papers/9449325 | PubMed |
| 3 | 9,679,158 | Transfer of rapid inactivation and sensitivity to the class III antiarrhythmic drug E-4031 from HERG to M-eag channels. | J Physiol | 1998 | https://conductscience.org/library/papers/9679158 | PubMed |
| 4 | 10,219,239 | MiRP1 forms IKr potassium channels with HERG and is associated with cardiac arrhythmia. | Cell | 1999 | https://conductscience.org/library/papers/10219239 | PubMed |
| 5 | 10,510,461 | Inhibition of the current of heterologously expressed HERG potassium channels by imipramine and amitriptyline. | Br J Pharmacol | 1999 | https://conductscience.org/library/papers/10510461 | PubMed |
| 6 | 15,541,373 | High affinity HERG K(+) channel blockade by the antiarrhythmic agent dronedarone: resistance to mutations of the S6 residues Y652 and F656. | Biochem Biophys Res Commun | 2004 | https://conductscience.org/library/papers/15541373 | PubMed |
| 7 | 15,673,388 | Further insights into the effect of quinidine in short QT syndrome caused by a mutation in HERG. | J Cardiovasc Electrophysiol | 2005 | https://conductscience.org/library/papers/15673388 | PubMed |
| 8 | 15,691,222 | Drugs, QT interval prolongation and ICH E14: the need to get it right. | Drug Saf | 2005 | https://conductscience.org/library/papers/15691222 | PubMed |
| 9 | 15,749,156 | Predicting drug-hERG channel interactions that cause acquired long QT syndrome. | Trends Pharmacol Sci | 2005 | https://conductscience.org/library/papers/15749156 | PubMed |
| 10 | 16,011,830 | The N588K-HERG K+ channel mutation in the 'short QT syndrome': mechanism of gain-in-function determined at 37 degrees C. | Biochem Biophys Res Commun | 2005 | https://conductscience.org/library/papers/16011830 | PubMed |
| 11 | 16,039,272 | Modulation of I(Kr) inactivation by mutation N588K in KCNH2: a link to arrhythmogenesis in short QT syndrome. | Cardiovasc Res | 2005 | https://conductscience.org/library/papers/16039272 | PubMed |
| 12 | 16,144,878 | QT prolongation and syncope with methadone, doxepin, and a beta-blocker. | Ann Pharmacother | 2005 | https://conductscience.org/library/papers/16144878 | PubMed |
| 13 | 16,301,704 | Short QT syndrome. | CMAJ | 2005 | https://conductscience.org/library/papers/16301704 | PubMed |
| 14 | 16,288,909 | Clemastine, a conventional antihistamine, is a high potency inhibitor of the HERG K+ channel. | J Mol Cell Cardiol | 2006 | https://conductscience.org/library/papers/16288909 | PubMed |
| 15 | 16,446,155 | Erythromycin block of the HERG K+ channel: accessibility to F656 and Y652. | Biochem Biophys Res Commun | 2006 | https://conductscience.org/library/papers/16446155 | PubMed |
| 16 | 16,423,345 | Inhibition of cardiac HERG potassium channels by antidepressant maprotiline. | Eur J Pharmacol | 2006 | https://conductscience.org/library/papers/16423345 | PubMed |
| 17 | 16,554,806 | hERG potassium channels and cardiac arrhythmia. | Nature | 2006 | https://conductscience.org/library/papers/16554806 | PubMed |
| 18 | 16,542,653 | Inhibition of the HERG K+ channel by the antifungal drug ketoconazole depends on channel gating and involves the S6 residue F656. | FEBS Lett | 2006 | https://conductscience.org/library/papers/16542653 | PubMed |
| 19 | 16,474,415 | Mechanism of hERG K+ channel blockade by the fluoroquinolone antibiotic moxifloxacin. | Br J Pharmacol | 2006 | https://conductscience.org/library/papers/16474415 | PubMed |
| 20 | 16,736,158 | Atypical tetracyclic antidepressant maprotiline is an antagonist at cardiac hERG potassium channels. | Naunyn Schmiedebergs Arch Pharmacol | 2006 | https://conductscience.org/library/papers/16736158 | PubMed |
Cited by17
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 43 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 37,195,310 | Precision Medicine in Antidepressants Treatment. | Handb Exp Pharmacol | 2023 | https://conductscience.org/library/papers/37195310 | PubMed |
| 36,142,644 | New Insights into Ion Channels: Predicting hERG-Drug Interactions. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/36142644 | PubMed |
| 35,560,982 | Inhibition of TRPC4 channel activity in colonic myocytes by tricyclic antidepressants disrupts colonic motility causing constipation. | J Cell Mol Med | 2022 | https://conductscience.org/library/papers/35560982 | PubMed |
| 32,252,558 | Drug-specific risk of severe QT prolongation following acute drug overdose. | Clin Toxicol (Phila) | 2020 | https://conductscience.org/library/papers/32252558 | PubMed |
| 28,814,790 | In silico investigation of a KCNQ1 mutation associated with short QT syndrome. | Sci Rep | 2017 | https://conductscience.org/library/papers/28814790 | PubMed |
| 28,592,292 | Effects of amiodarone on short QT syndrome variant 3 in human ventricles: a simulation study. | Biomed Eng Online | 2017 | https://conductscience.org/library/papers/28592292 | PubMed |
| 27,891,211 | From linked open data to molecular interaction: studying selectivity trends for ligands of the human serotonin and dopamine transporter. | Medchemcomm | 2016 | https://conductscience.org/library/papers/27891211 | PubMed |
| 24,877,995 | Ranolazine inhibition of hERG potassium channels: drug-pore interactions and reduced potency against inactivation mutants. | J Mol Cell Cardiol | 2014 | https://conductscience.org/library/papers/24877995 | PubMed |
| 21,777,565 | The hERG K(+) channel S4 domain L532P mutation: characterization at 37°C. | Biochim Biophys Acta | 2011 | https://conductscience.org/library/papers/21777565 | PubMed |
| 21,660,488 | Predicting the potency of hERG K⁺ channel inhibition by combining 3D-QSAR pharmacophore and 2D-QSAR models. | J Mol Model | 2012 | https://conductscience.org/library/papers/21660488 | PubMed |
| 20,229,012 | Multiple mechanisms of hERG liability: K+ current inhibition, disruption of protein trafficking, and apoptosis induced by amoxapine. | Naunyn Schmiedebergs Arch Pharmacol | 2010 | https://conductscience.org/library/papers/20229012 | PubMed |
| 20,150,828 | KCNH2 pharmacogenomics summary. | Pharmacogenet Genomics | 2010 | https://conductscience.org/library/papers/20150828 | PubMed |
| 19,916,999 | Sudden death in patients receiving drugs tending to prolong the QT interval. | Br J Clin Pharmacol | 2009 | https://conductscience.org/library/papers/19916999 | PubMed |
| 19,720,020 | Transfer of rolf S3-S4 linker to HERG eliminates activation gating but spares inactivation. | Biophys J | 2009 | https://conductscience.org/library/papers/19720020 | PubMed |
| 18,724,381 | Pharmacology of the short QT syndrome N588K-hERG K+ channel mutation: differential impact on selected class I and class III antiarrhythmic drugs. | Br J Pharmacol | 2008 | https://conductscience.org/library/papers/18724381 | PubMed |
| 18,542,937 | Impaired heart rate variability and altered cardiac sympathovagal balance after antidepressant overdose. | Eur J Clin Pharmacol | 2008 | https://conductscience.org/library/papers/18542937 | PubMed |
| 18,458,880 | Inhibition of cardiac hERG potassium channels by tetracyclic antidepressant mianserin. | Naunyn Schmiedebergs Arch Pharmacol | 2008 | https://conductscience.org/library/papers/18458880 | PubMed |
Genes3
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| ERG | 2,078 | PubTator's text mining | https://conductscience.org/library/genes/2078 | NCBI Gene |
| KCNE2 | 9,992 | PubTator's text mining | https://conductscience.org/library/genes/9992 | NCBI Gene |
| KCNH2 | 3,757 | PubTator's text mining | https://conductscience.org/library/genes/3757 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/17560554
GET https://conductscience.org/api/papers/v1/17560554/references?page=2